Total Funding
1
4
Total FundingPost-IPO Equity raised
Growth Score
-3 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3475260
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Acquired by 
Bausch Health
Carolyn Logan: CEOPast Role: Salix Pharmaceuticals, Senior Vice President, Sales and Marketing
Thomas Hadley: VP - Head of Marketing
About the Company
Salix Pharmaceuticals is a specialty pharmaceutical company committed to the prevention and treatment of gastrointestinal (GI) disorders. For more than 20 years, they have licensed, developed, and marketed innovative products to treat GI problems. It's their mission to give healthcare providers and patients the most effective solutions in
gastroenterology.
Women Led
